Your blog category
Hope they get this ironed out quick. Basically their suspend alarm isn’t working as documented.
Mine — a IR1000 — hollars at me every few minutes, which is handy when you disconnect to go to the hot tub, and you have your glasses on and they are fogged. Taking them out doesn’t help, because you can’t sen then either.
I think, in fact, I’m pretty sure a dentist gave me Vioxx for a few days after a root canal.
This isn’t the first drug I’ve taken that’s been pulled. Fen-Fen — which I took for a week and hated the dry mouth … and I was on a gastric reflux medication that was pulled, I can’t remember the name, but man, did it work. I slept the best on that medication…
Vioxx Pulled From Global Market
Merck & Co., Inc., announced today a voluntary withdrawal of rofecoxib (Vioxx) from the U.S. and worldwide market due to safety concerns of an increased risk of cardiovascular events, according to an alert from MedWatch, the U.S. Food and Drug Administration (FDA) safety information and adverse event reporting program.
Chronic Insulin Use Increases Risk of Colorectal Cancer in Type 2 Diabetics
Chronic insulin therapy significantly increases the risk of colorectal cancer (CRC) in patients with type 2 diabetes mellitus (DM), according to the results of a retrospective cohort study published in the October issue of Gastroenterology.
Another difference between the two types is gone.
Type 2 Diabetics Not Immune to Diabetic Ketoacidosis
A significant portion of diabetic ketoacidosis (DKA) cases occur in patients with type 2 diabetes, according to the results of a review of admissions published in the Sept. 27 issue of the Archives of Internal Medicine. There are subtle differences from DKA in patients with type I diabetes, but the treatment is the same.
“An episode of DKA was once considered a hallmark feature that would differentiate individuals with type 1 diabetes mellitus from those with type 2 diabetes mellitus,” write Christopher A. Newton, MD, and Philip Raskin, MD, from the University of Texas Southwestern Medical Center at Dallas. “With the changes in the frequency of DKA and the increased incidence of DKA in patients with type 2 diabetes mellitus, the question may be posed of whether there has been any change in the clinical or laboratory characteristics of the patients with DKA who present to the emergency department.”
Newer insulins and easier blood glucose monitoring have greatly improved the ability to obtain excellent control of blood glucose levels with less risk of hypoglycemia. In type 1 diabetes, insulin pump therapy remains the optimal approach with the most flexibility, especially with the ultra-fast-acting analogs lispro or aspart. Otherwise, once- or twice-daily dosing with the long-acting analog glargine provides excellent basal coverage, and lispro or aspart at meals provides bolus coverage, all in the attempt to mimic physiological insulin secretion. For type 2 diabetes, although oral agents continue to be a mainstay of therapy, it is clear that many patients require insulin to attain the goal A1c of < 6.5%. Once-daily glargine is now used more commonly after 1-2 oral agents have failed, and it typically takes the place of sulfonylureas. The future will likely have better systems for continuous glucose monitoring and novel therapies to control glucose through agents that affect gut hormones.
Right now, continuous glucose monitoring really doesn’t seem feasible, even in the very near future. It’s also expensive!
This is a good article reviewing the state of technology though. I will say, as a Type 2 diabetic, I STILL hate any of the longer acting insulin. Their release just isn’t as perdictable as the fast acting in a pump. Plus, if you get up and you end up running around the room all day, the only way to deal with the excess insulin is eating, thus incurring weight gain.
Health Beat :: America has heartburn
Back when Prilosec worked for me, and it was a prescription drug, the pharmacy’s would run out of Prilosec back then too. Makes me wonder if the manufacturer does it on purpose.
Which may be why the Glucowatch hasn’t been successful.
I bet the blood sugar monitor required one too.
There are two points to this story — to illustrate another way that apologizing isn’t acceptable —
And to illustrate what happens when blood sugar is out of control.
A couple of years ago, right after being diagnosed with diabetes and
with a blood sugar of over 400 … a teacher aide interrupted one of
my classes. I politely asked her to leave, and when she continued to
interrupt my class time by standing in front of the computer I was
doing the demonstration on, I yelled at her to get out of my room.
Probably a bit strong of a reaction, and if my blood sugar had been
lower, I might have not yelled as quickly. Woman never DID budge.
As a result, she complained to one of the administrators, and I
refused to back down. Geez, it was MY classroom, I was teaching MY
class, and she was interrupting. I ended up discussing it with the
principal, and no one ever did acknowledge interrupting me put her in
the wrong.
To mollify everyone involved, I agreed to let her come up to my
classroom, introduce her to my students, and apologize to her in front
of them. She wouldn’t accept anything less.
My students were appalled! I told them what was happening the day before she came.
And after she left, I let them know that while the witnesses agreed she was in the wrong, third parties had determined that I needed to apologize and it wasn’t a big deal for me. I truly
shouldn’t have yelled, even if she wasn’t listening.
Good things came of it. My students learned that apologizing for
misbehavior — justified or not — is not that big of a deal, and the
aide and I are at least cordial, and she sees things my way now.
She also hasn’t interrupted a class of mine since.
And due to posts from the insulin-pumpers list, I believe they are starting to ship
FDA Approves Geodon, Alimta, Vioxx, and Others
On June 28, the FDA approved a blood glucose module (CoZmonitor, made by Smiths Medical MD, Inc., formerly Deltec, Inc.), intended for attachment to the back of the Deltec Cozmo insulin pump to create an “all in one” insulin pump and blood glucose monitoring system. The pump keypad and screen are used for all blood glucose testing functions and results.